Company intelligence / Profile preview

AAVnerGene

Rockville, Maryland, United Statesaavnergene.com ↗

Ownership: Private
Development stage: Preclinical

Overview

AAVnerGene has developed proprietary platforms that significantly improve the efficiency, scalability, and specificity of adeno-associated virus vector production. Their ATHENA platform enables high-throughput screening and evolution of novel capsids tailored to specific applications. The company’s innovations address key bottlenecks in gene therapy manufacturing but there are no public reports of their own clinical trial results as they primarily serve as a technology enabler for others in the field

Therapeutic areas: Other
Modalities: Adeno-associated virus (AAV) vectors and gene therapy technologies
Industry: Contract Manufacturing Organization

Partnerships

Collaborates with academic institutions and biotech companies to advance gene therapy projects but no major named pharmaceutical partnerships publicly disclosed as of May 2025

Beyond the preview

Go deeper on AAVnerGene.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AAVnerGene.

Explore the full profile